Get alerts of updates about «Buprenorphine versus methadone for pregnant women in opioid maintenance treatment (OMT)»
You have subscribed to alerts about:
- Buprenorphine versus methadone for pregnant women in opioid maintenance treatment (OMT)
Project
Buprenorphine versus methadone for pregnant women in opioid maintenance treatment (OMT) - project description
Published Updated
We will systematically summarise research on short- and long-term effects for mother, foetus and child of buprenorphine- versus methadone-based maintenance treatment during pregnancy.
Summary
It is unclear whether opioid dependent women in fertile age should be recommended buprenorphine or methadone when they enter opioid maintenance treatment (OMT). We will systematically summarise research on short- and long-term effects for mother, foetus and child of buprenorphine- versus methadone-based maintenance treatment during pregnancy.
See the full project description at Cristin for more information about results, researchers, contact information etc.
Project participants
Project leader
Hege Kornør, Avdeling for vurdering av tiltak, Norwegian Institute of Public Health
Project participants
Hilde Strømme, Avdeling for vurdering av tiltak, Norwegian Institute of Public Health
Kristin Thuve Dahm, Avdeling for vurdering av tiltak, Norwegian Institute of Public Health
-
Related documents